Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Kempharm Inc (KMPH)

Kempharm Inc (KMPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kempharm Inc 1180 Celebration Boulevard Suite 103 Celebration FL 34747 USA

P: 321-939-3416

Description:

KemPharm Inc. is a specialty pharmaceutical company which is engaged in the discovery and development of new molecular entity prodrugs. Its product candidates include KP201/APAP, KP511/ER and KP606/ER for the treatment of pain; KP415 for the treatment of attention deficit hyperactivity disorder and KP303 for the treatment of central nervous system disorders, which are in preclinical trail stage. The Company through its LAT platform technology generate prodrug. KemPharm Inc. is based in CORALVILLE, United States.

Key Statistics

Overview:

Market Capitalization, $K 215,243
Enterprise Value, $K 102,893
Shares Outstanding, K 34,494
Annual Sales, $ 28,650 K
Annual Net Income, $ -8,560 K
Last Quarter Sales, $ 1,300 K
Last Quarter Net Income, $ -24,040 K
60-Month Beta 2.78
% of Insider Shareholders 1.10%
% of Institutional Shareholders 20.85%
Float, K 34,115
% Float 98.90%
Short Volume Ratio 0.52

Growth:

1-Year Return -33.12%
3-Year Return -42.65%
5-Year Return -89.67%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 93.20%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.19 on 08/11/22
Next Earnings Date 11/09/22
Earnings Per Share ttm -0.31
EPS Growth vs. Prev Qtr -216.67%
EPS Growth vs. Prev Year 52.50%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-16 on 12/28/20

KMPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -10.80%
Return-on-Assets % -9.96%
Profit Margin % -29.88
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 7.14
Price/Cash Flow 23.76
Price/Book 2.06
Book Value/Share 2.88
Interest Coverage -21.42
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar